Drug intelligence / Profile preview

X92001752

Development stage: Unknown
Lead developer: Oystershell
Administration: Topical

Overview

X92001752 is the code name for a test product evaluated in a clinical trial as a **suffocating head lice treatment**. It was investigated in a head-to-head study against three other pediculicide (lice-killing) products, including two medical devices and one conventional pesticide. The trial primarily assessed the efficacy and safety of X92001752 in the management of head lice infestations in humans[2][3]. No information on the precise active ingredient, mechanism of action, or commercial brand name is available in public sources.

Beyond the preview

Go deeper on X92001752.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on X92001752.

Explore the full profile